Skip to content

PGBioclin: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PGBioclin

BE 0747.635.715
NACE 72.109, Other research and development on natural sciences
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€90,119
2024 · €233,313-€143,194
Equity
€5,495
2024 · €144,375-€138,881
Cash
€3,682
2024 · €8,338-€4,656
Balance sheet total
€208,043
2024 · €179,010+€29,033

Largest movements

2024 to 2025
Assets
  • Current investments +€31,610

    up €31,610 (+38.7%), from €81,612 to €113,222

  • Receivables within one year +€20,069

    up €20,069 (+286%), from €7,016 to €27,085

    of which Other amounts receivable: +€20,069

  • Tangible fixed assets -€17,322

    down €17,322 (-21.8%), from €79,583 to €62,260

    of which Furniture and vehicles: -€14,919

  • Cash -€4,656

    down €4,656 (-55.8%), from €8,338 to €3,682

    mainly Contributions, distributions and other (-€229,000) and Tax, wage and social debts (-€34,634)

Equity and liabilities
  • Other debts +€192,505

    up €192,505, from €0 to €192,505

  • Profit (loss) carried forward -€138,881

    down €138,881 (-99.6%), from €139,375 to €495

  • Tax, wage and social debts -€34,634

    down €34,634 (-100%), from €34,634 to €0

    of which Taxes: -€34,634

  • Short-term financial debts +€9,998

    new in 2025: €9,998

Income statement
  • Gross operating margin -€167,525

    down €167,525 (-55.2%), from €303,343 to €135,818

  • Taxes -€42,554

    down €42,554 (-62.8%), from €67,734 to €25,181

  • Depreciation +€13,612

    up €13,612 (+367%), from €3,710 to €17,322

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €233,313
Gross operating margin -€167,525
Depreciation -€13,612
Other operating charges -€2,773
Financial income -€1,805
Financial charges -€32
Taxes +€42,554
Result 2025 €90,119
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€245,956
Investment -€31,610
Financing -€219,002
Cash 2024 €8,338
Net result for the year +€90,119
Depreciation +€17,322
Receivables within one year -€20,069
Deferred charges and accrued income +€667
Trade debts +€45
Tax, wage and social debts -€34,634
Other debts +€192,505
Current investments -€31,610
Short-term financial debts +€9,998
Contributions, distributions and other -€229,000
Cash 2025 €3,682
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €179,010 €208,043 +€29,033 +16.2%
Fixed assets 21/28 €79,583 €62,260 -€17,322 -21.8%
Tangible fixed assets 22/27 €79,583 €62,260 -€17,322 -21.8%
Plant, machinery and equipment 23 €5,758 €3,971 -€1,787 -31.0%
Furniture and vehicles 24 €72,058 €57,140 -€14,919 -20.7%
Other tangible fixed assets 26 €1,766 €1,150 -€616 -34.9%
Current assets 29/58 €99,427 €145,782 +€46,355 +46.6%
Amounts receivable within one year 40/41 €7,016 €27,085 +€20,069 +286%
Trade receivables 40 €0 - =
Other amounts receivable 41 €7,016 €27,085 +€20,069 +286%
Current investments 50/53 €81,612 €113,222 +€31,610 +38.7%
Cash at bank and in hand 54/58 €8,338 €3,682 -€4,656 -55.8%
Deferred charges and accrued income 490/1 €2,461 €1,794 -€667 -27.1%
Total equity and liabilities 10/49 €179,010 €208,043 +€29,033 +16.2%
Equity 10/15 €144,375 €5,495 -€138,881 -96.2%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €139,375 €495 -€138,881 -99.6%
Amounts payable 17/49 €34,634 €202,548 +€167,914 +485%
Amounts payable within one year 42/48 €34,634 €202,548 +€167,914 +485%
Financial debts 43 - €9,998 +€9,998
Credit institutions 430/8 - €9,998 +€9,998
Trade debts 44 €0 €45 +€45
Suppliers 440/4 - €45 +€45
Taxes, remuneration and social security 45 €34,634 €0 -€34,634 -100%
Taxes 450/3 €34,634 €0 -€34,634 -100%
Remuneration and social security 454/9 €0 - =
Other amounts payable 47/48 €0 €192,505 +€192,505
Non-recurring operating income 76A €14,361 - -€14,361
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,710 €17,322 +€13,612 +367%
Other operating charges 640/8 €903 €3,676 +€2,773 +307%
Gross operating margin 9900 €303,343 €135,818 -€167,525 -55.2%
Operating profit (loss) 9901 €298,731 €114,820 -€183,911 -61.6%
Financial income 75/76B €2,415 €610 -€1,805 -74.7%
Recurring financial income 75 €2,415 €610 -€1,805 -74.7%
Financial charges 65/66B €98 €130 +€32 +32.7%
Recurring financial charges 65 €98 €130 +€32 +32.7%
Profit (loss) for the period before taxes 9903 €301,048 €115,300 -€185,748 -61.7%
Income taxes 67/77 €67,734 €25,181 -€42,554 -62.8%
Profit (loss) for the period 9904 €233,313 €90,119 -€143,194 -61.4%
Profit (loss) for the period to be appropriated 9905 €233,313 €90,119 -€143,194 -61.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.